课题基金 / 基金详情

Role of 5-HT1A-AR overexpression in affective disorders

Role of 5-HT1A-AR overexpression in affective disorders
5-HT1A-AR 过表达在情感障碍中的作用
批准号:
7281976
负责人:
Miles Berger
金额:
$3.01万
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-09-01 至 2008-08-31

项目摘要

项目成果

Miles Berger的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):严重抑郁症是一种常见的精神疾病,被认为部分是由于血清素(5-HT)神经传递减少引起的。 最近的证据表明,这种减少可能是由于5-HT神经元上抑制性5-HT 1A自身受体(5-HT 1A-AR)表达增加所致。为了模拟抑郁症病理生理学的这一方面,我已经创建了旨在过表达5-HT 1A-AR的转基因小鼠;我假设这些小鼠将减少5-HT传输和抑郁样行为。 目的1:应用定量放射自显影和免疫细胞化学技术检测转基因小鼠中β 5-HT 1A-AR的表达。 目的2:通过在体微透析和电生理研究5-HT 1A-AR过表达对5-HT神经传递的影响。目的3:确定5-HT 1A-AR过表达在神经植物功能和抑郁样行为测试中的作用。这些研究应该增加我们对抑郁症和其他情感障碍的根本原因的理解,并可能为患有这些疾病的患者带来新的治疗策略。
英文摘要
DESCRIPTION (provided by applicant): Major depression is a common mental illness thought to arise in part from decreased serotonin (5-HT) neurotransmission. Recent evidence suggests that this decrease may arise from increased expression of inhibitory 5-HT1A autoreceptors (5-HT1A-AR) on 5-HT neurons. To model this aspect of the pathophysiology of depression, I have created transgenic mice designed to overexpress 5-HT1A-AR; I hypothesize that these mice will have decreased 5-HT transmission and depressive-like behavior. Aim 1: Validate 5-HT1A-AR overexpression in transgenic mice by quantitative autoradiography and immunocytochemistry. Aim 2: Determine the effect of 5-HT1A-AR overexpression on 5-HT neurotransmission by in vivo microdialysis and electrophysiology. Aim 3: Determine the effect of 5-HT1A-AR overexpression in tests of neurovegetative function and depressive-like behavior. These studies should increase our understanding of the underlying causes of depression and other affective disorders, and may lead to new treatment strategies for patients suffering from these disorders.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOE4 dependent regulation of CSF Complement Pathway Activation in the development of Alzheimer's Disease
  • 批准号:
    10650372
  • 项目类别:
  • 资助金额:
    $78.47万
  • 财政年份:
    2022
  • 负责人:
    Miles Berger
  • 依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
  • 批准号:
    10870632
  • 项目类别:
  • 资助金额:
    $33.63万
  • 财政年份:
    2022
  • 负责人:
    Miles Berger
  • 依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
  • 批准号:
    10671023
  • 项目类别:
  • 资助金额:
    $74.98万
  • 财政年份:
    2022
  • 负责人:
    Miles Berger
  • 依托单位:
Low Neurophysiologic Resistance to Anesthetics as a Marker of Preclinical/Prodromal Alzheimer's Disease and Neurovascular Pathology, Delirium risk and Inattention
  • 批准号:
    10521860
  • 项目类别:
  • 资助金额:
    $78.42万
  • 财政年份:
    2022
  • 负责人:
    Miles Berger
  • 依托单位:
国内基金
海外基金
Agonist-GPR119-Gs复合物的结构生物学研究
  • 批准号:
    32000851
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2020
  • 负责人:
    乔安娜
  • 依托单位: